CONGESTIVE HEART FAILURE BIOMARKERS

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20140364334A1
SERIAL NO

14366194

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention provides gene and protein markers for cardiac disease and methods for using them to identify patients at risk for developing heart failure, or patients in an early stage of heart failure whose disease is likely to advance to a later stage. The present invention allows a treatment provider to identify those patients whose disease is most likely to develop and/or advance, and to initiate and/or adjust treatment options for such patients accordingly.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
NUCLEA BIOTECHNOLOGIES INC105 SOUTH STREET PITTSFIELD MA 01201

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Muraca, Patrick J Pittsfield, US 48 438

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation